Federal Register / Vol. 80, No. 18 / Wednesday, January 28, 2015 / Notices 4581 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Targeting 

Temporal Dynamics of the Brain Activity for 

the Treatment of Cognitive Deficits. 

Date: February 17–18, 2015. 

Time: 8:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Wei-Qin Zhao, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5181 

MSC 7846, Bethesda, MD 20892–7846, 301– 

435–1236, zhaow@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Academic 

Research Enhancement Award. 

Date: February 25, 2015. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Lee Rosen, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5116, 

MSC 7854, Bethesda, MD 20892, (301) 435– 

1171, rosenl@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Drug Discovery for Aging, 

Neuropsychiatric and Neurologic Disorders. 

Date: February 26–27, 2015. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: J W Marriott New Orleans, 614 

Canal Street, New Orleans, LA 70130. 

Contact Person: Yuan Luo, Ph.D., Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 5207, MSC 7846, Bethesda, MD 

20892, 301–915–6303, luoy2@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Sensory and Motor 

Neurosciences, Cognition and Perception. 

Date: February 26–27, 2015. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: JW Marriott Hotel, 614 Canal St, 

New Orleans, LA 70130. 

Contact Person: Sharon S Low, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5104, 

MSC 7846, Bethesda, MD 20892, 301–237– 

1487, lowss@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Aging and Development, Auditory, 

Vision and Low Vision Technologies. 

Date: February 26–27, 2015. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites DC Convention 

Center, Embassy Hotel, 900 10th street, 

Washington, DC 20001. 

Contact Person: Paek-Gyu Lee, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4201, 

MSC 7812, Bethesda, MD 20892, (301) 613– 

2064, leepg@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Medical Imaging. 

Date: February 26–27, 2015. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Los Angeles Marriott at LAX, 5855 

West Century Blvd., Los Angeles, CA 90245. 

Contact Person: Leonid V Tsap, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5128, 

MSC 7854, Bethesda, MD 20892, (301) 435– 

2507, tsapl@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Fellowship: 

Immunology. 

Date: February 26–27, 2015. 

Time: 8:30 a.m. to 5:00 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Residence Inn Bethesda, 7335 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Patrick K Lai, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2215, 

MSC 7812, Bethesda, MD 20892, 301–435– 

1052, laip@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Basic and Integrative 

Bioengineering. 

Date: February 26, 2015. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

Contact Person: Paul Sammak, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6185, 

MSC 7892, Bethesda, MD 20892, 301–435– 

0601, sammakpj@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflicts: Bioengineering Sciences. 

Date: February 26–27, 2015. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Ping Fan, MD, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5154, 

MSC 7840, Bethesda, MD 20892, 301–408– 

9971, fanp@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PARs: 

Developmental Pharmacology and 

Toxicology. 

Date: February 26, 2015. 

Time: 1:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Bonnie L Burgess-Beusse, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2182, 

MSC 7818, Bethesda, MD 20892, 301–435– 

1783, beusseb@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel. 

Date: February 26, 2015. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: David R Filpula, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6181, 

MSC 7892, Bethesda, MD 20892, 301–435– 

2902, filpuladr@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Musculoskeletal Rehabilitation. 

Date: February 26, 2015. 

Time: 4:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Admiral Fell Inn, 888 South 

Broadway, Baltimore, MD 21231. 

Contact Person: Rajiv Kumar, Ph.D., IRG 

Chief, Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Room 4216, MSC 7802, Bethesda, MD 20892, 

301–435–1212, kumarra@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846-93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

mstockstill on DSK4VPTVN1PROD with NOTICES

4582 Federal Register / Vol. 80, No. 18 / Wednesday, January 28, 2015 / Notices 

Dated: January 22, 2015. 

Carolyn Baum, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–01486 Filed 1–27–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[Docket No. USCG–2014–0720] 

Request for Public Comment on 

Waiver Revisions for Certain 

Medications and Suggestions for Risk 

Evaluation 

AGENCY: Coast Guard, DHS. 

ACTION: Notice of proposed policy 

clarification and request for comments. 

SUMMARY: The Coast Guard is seeking 

public comment on the policy 

clarification proposed in this Notice 

regarding the criteria for granting 

medical waivers to mariners who 

require the use of potentially impairing 

prescription medications. The Coast 

Guard is also seeking input regarding 

effective methods of risk evaluation of 

such mariners. Current Coast Guard 

guidance states that the ‘‘use of certain 

medications is considered disqualifying 

for the issuance of credentials,’’ and that 

‘‘the underlying cause or need for use of 

these medications and potential side 

effects may result in denial of a 

credential application or require a 

waiver.’’ Current guidance specifically 

identifies that use of benzodiazepine 

medications, opioid and opiate 

medications, non-benzodiazepine 

sedative hypnotic medications, and 

barbiturate medications require a 

waiver, but does not specify the factors 

that the Coast Guard will consider in 

making its determination on whether 

the risks associated with use of these 

medications are low enough to warrant 

consideration for a waiver. 

The Coast Guard is proposing 

additions to the current medication 

policy that will clarify the 

circumstances that the Coast Guard will 

consider when determining whether to 

grant a medical waiver for use of these 

medications. Additionally, the Coast 

Guard is proposing to include a safety 

warning to mariners advising them to 

refrain from use of impairing 

medications while operating under the 

authority of their credential. The Coast 

Guard is seeking comments from the 

public on whether the proposed policy 

adequately addresses safety concerns 

regarding merchant mariners whose 

medical conditions require the use of 

medications that have the potential to 

impair cognitive ability, judgment or 

reaction time. 

DATES: Comments and related material 

must either be submitted to our online 

docket via http://www.regulations.gov 

on or before March 30, 2015 or reach the 

Docket Management Facility by that 

date. 

ADDRESSES: You may submit comments 

identified by docket number USCG– 

2014–0720 using any one of the 

following methods: 

(1) Federal eRulemaking Portal: 

http://www.regulations.gov. 

(2) Fax: 202–493–2251. 

(3) Mail: Docket Management Facility 

(M–30), U.S. Department of 

Transportation, West Building Ground 

Floor, Room W12–140, 1200 New Jersey 

Avenue SE., Washington, DC 20590– 

0001. 

(4) Hand delivery: Same as mail 

address above, between 9 a.m. and 5 

p.m., Monday through Friday, except 

Federal holidays. The telephone number 

is 202–366–9329. 

To avoid duplication, please use only 

one of these four methods. See the 

‘‘Public Participation and Request for 

Comments’’ portion of the 

SUPPLEMENTARY INFORMATION section 

below for instructions on submitting 

comments. 

FOR FURTHER INFORMATION CONTACT: If 

you have questions about this notice, 

call or email Lieutenant Ashley Holm, 

Mariner Credentialing Program Policy 

Division (CG–CVC–4), U.S. Coast Guard, 

telephone 202–372–2357, email 

MMCPolicy@uscg.mil. If you have 

questions on viewing material in the 

docket, call Docket Operations at 202– 

366–9826. 

SUPPLEMENTARY INFORMATION: 

Public Participation 

You may submit comments and 

related material regarding whether the 

policy clarifications proposed in this 

Notice should be incorporated into a 

final policy on issuing medical waivers 

to mariners whose medical conditions 

require use of benzodiazepine 

medications, opioid and opiate 

medications, non-benzodiazepine 

sedative hypnotic medications, or 

barbiturate medications. All comments 

received will be posted, without change, 

to http://www.regulations.gov and will 

include any personal information you 

have provided. 

Submitting Comments 

If you submit a comment, please 

include the docket number for this 

notice (USCG–2014–0720) and provide 

a reason for each suggestion or 

recommendation. You may submit your 

comments and material online or by fax, 

mail or hand delivery, but please use 

only one of these means. We 

recommend that you include your name 

and a mailing address, an email address, 

or a telephone number in the body of 

your document so that we can contact 

you if we have questions regarding your 

submission. 

To submit your comment online, go to 

http://www.regulations.gov, type the 

docket number (USCG–2014–0720) in 

the ‘‘SEARCH’’ box and click 

‘‘SEARCH.’’ Click on ‘‘Submit a 

Comment’’ on the line associated with 

this notice. 

If you submit your comments by mail 

or hand delivery, submit them in an 

unbound format, no larger than 81⁄2 by 

11 inches, suitable for copying and 

electronic filing. If you submit them by 

mail and would like to know that they 

reached the Facility, please enclose a 

stamped, self-addressed postcard or 

envelope. We will consider all 

comments and material received during 

the comment period. 

Viewing the comments: To view 

comments, go to http://

www.regulations.gov, type the docket 

number (USCG–2014–0720) in the 

‘‘SEARCH’’ box and click ‘‘SEARCH.’’ 

Click on ‘‘Open Docket Folder’’ on the 

line associated with this rulemaking. 

You may also visit the Docket 

Management Facility in Room W12–140 

on the ground floor of the Department 

of Transportation West Building, 1200 

New Jersey Avenue SE., Washington, 

DC 20590, between 9 a.m. and 5 p.m., 

Monday through Friday, except Federal 

holidays. We have an agreement with 

the Department of Transportation to use 

their Docket Management Facility. 

Privacy Act: Anyone can search the 

electronic form of comments received 

into any of our dockets by the name of 

the individual submitting the comment 

(or signing the comment, if submitted 

on behalf of an association, business, 

labor union, etc.). You may review a 

Privacy Act system of records notice 

regarding our public dockets in the 

January 17, 2008, issue of the Federal 

Register (73 FR 3316). 

Background and Purpose 

Coast Guard regulations in 46 CFR 

10.302 contain the medical standards 

that merchant mariners must meet prior 

to being issued a merchant mariner 

credential (MMC). In cases where the 

mariner does not meet the medical 

standards in 46 CFR 10.302, waivers 

may be granted when extenuating 

circumstances exist that warrant special 

consideration. 46 CFR 10.303. 

Additionally, 46 CFR 10.304 specifies 

mstockstill on DSK4VPTVN1PROD with NOTICES